SCHEMBL4673075

SCHEMBL4673075

O=C(c1ccccc1F)C([CH]C1CCNCC1)C1CCNCC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.42
CES1 P23141 2/20 0.42
KDM1A O60341 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SLC6A2 P23975 5/20 0.35
SLC6A3 Q01959 5/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX15 P16050 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SLC6A4 P31645 4/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11130129 0.85 CES2 (0.43) CES2CES1KDM1ASLC6A2SLC6A3
SCHEMBL4670554 0.85 CES2 (0.45) CES2CES1NPC1RAB9ASLC6A2
SCHEMBL4672728 0.78 MAOB (0.38) CES2CES1RAB9ASLC6A2SLC6A3
SCHEMBL4670634 0.75 RAB9A (0.40) CES2CES1NPC1RAB9AALDH1A1
SCHEMBL4676042 0.74 CHRNA7 (0.40) CES2CES1NPC1RAB9AALDH1A1
SCHEMBL4673078 0.74 CES2 (0.42) CES2CES1SLC6A2SLC6A3SLC6A4
SCHEMBL1729357 0.72 RXFP1 (0.37) RAB9ASLC6A2SLC6A3KMT2ASLC6A4
SCHEMBL4674063 0.72 SLC6A2 (0.40) NPC1RAB9ASLC6A2SLC6A3MEN1
SCHEMBL9851969 0.69 HTR3E (0.55) CES2CES1SLC6A2SLC6A3ALDH1A1
SCHEMBL20475037 0.69 TP53 (0.41) CES2CES1NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899324-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS Theravance, Inc. (US) 2008-03-19 EP claimed
WO-2006127815-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE, INC. (US) 2006-11-30 WO claimed
EP-1899324-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS Theravance, Inc. (US) 2008-03-19 EP disclosed
WO-2006127815-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE, INC. (US) 2006-11-30 WO disclosed